Noam Benyamini
8, Ha'Aliya Street
Haifa, HA 31096, Israel
Haifa, HA 31096, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study.
Journal: British journal of haematology
Published: March 31, 2026
Bringing the hospital home: exploring the challenges and perspectives of healthcare professionals on home treatment in hemato-oncology: a qualitative analysis.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: March 11, 2026
Response rates of extra-nodal diffuse large B cell lymphoma to anti-CD19-CAR T cells: A real word retrospective multicenter study.
Journal: European journal of haematology
Published: January 18, 2023
COVID-19 in patients with lymphoproliferative diseases during the Omicron variant surge.
Journal: Cancer cell
Published: April 27, 2022
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.
Journal: Annals of hematology
Published: October 25, 2021
Characteristics and recognition of early infections in patients treated with commercial anti-CD19 CAR-T cells.
Journal: European journal of haematology
Published: July 23, 2021
Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.
Journal: Transplantation and cellular therapy
Published: May 27, 2021
Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study.
Journal: Therapeutic advances in hematology
Published: May 02, 2021
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma.
Journal: Blood advances
Published: April 26, 2021
Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma.
Journal: British journal of haematology
Published: April 09, 2021
Lower Patient Anxiety and Unchanged Levels of Adherence to Hemato-Oncologic Treatment in Response to New Measures to Reduce Hospital Exposure Risk to COVID-19.
Journal: Patient preference and adherence
Published: February 23, 2021
Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience.
Journal: Leukemia & lymphoma
Published: September 28, 2020
Last Updated: 09/26/2026